1. Home
  2. News
  3. Sudarshan Pharma Industries Ltd
  4. Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
More Sudarshan Pharma Industries Ltd news
Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

Sep 9, 2026 at 10:27 AM EDT · Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE · Sep 9, 2026 at 10:27 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/revised-disclosures-under-reg-311-and-312-of-sebi-sast-regulations-2011-17

Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

  • Sudarshan Pharma Industries Ltd Press Release Sep 01 2026Sep 1
  • Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 1
  • Sudarshan Pharma Industries Ltd Press Release Aug 29 2026Aug 29
  • Reg. 34 (1) Annual Report.Aug 29
  • Annual General Meeting Of The Company On Tuesday, 22/September/2026Aug 29

Later from Sudarshan Pharma Industries

  • Sudarshan Pharma Industries Ltd Press Release Sep 09 2026Sep 9
  • Closure of Trading WindowSep 30
  • Sudarshan Pharma Industries Ltd Press Release Sep 30 2026Sep 30
  • Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 7
  • Announcement under Regulation 30 (LODR)-Updates on AcquisitionOct 7
All Sudarshan Pharma Industries news releases↗

Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.

Follow Sudarshan Pharma Industries
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer